Clinical trial Recruiting at 2 sites Phase 1 Interventional Ages 21 to 75

Effects of a high CBD cannabis extract on pain in Complex Regional Pain Syndrome

Official title: A Randomized, Double-blind, Placebo-controlled Study to Investigate the Effects and Mechanisms of a High CBD Cannabis Extract (BRC-002) for the Treatment of Pain and Health in Complex Regional Pain Syndrome

Run by University of California, San Diego · NCT06393101 · Data updated 2026-11-12

This study is testing whether a high CBD cannabis extract can help people with Complex Regional Pain Syndrome find relief from their pain.

More Complex Regional Pain Syndromes trials

Quick facts

PhasePhase 1
Study typeInterventional
Ages21 Years to 75 Years
SexAll
Enrollment52 (estimated)
SponsorUniversity of California, San Diego
Academic / other
Locations2 sites (La Jolla, California and 1 other locations)
StatusRecruiting
StartedJune 1, 2024
Main results expectedJune 1, 2029
Study endsJune 1, 2029
Registry record updatedJune 7, 2024
Trial IDNCT06393101 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 21-75 with a confirmed diagnosis of CRPS for at least three months who have been cannabis-free for 30 days prior to participation.

Probably not a fit

Patients with active pulmonary disease or those who have had adverse reactions to cannabis may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This trial aims to explore the effects and mechanisms of a high CBD cannabis extract (BRC-002) on pain relief in individuals suffering from Complex Regional Pain Syndrome (CRPS). It employs multiple psychophysical assessments alongside psychological and inflammatory marker testing to evaluate how cannabinoids may lead to sustained improvements in pain and related symptoms. The study includes a pre-treatment screening phase, a six-week treatment period, and a two-week follow-up to monitor outcomes. Participants will be closely monitored to ensure compliance with cannabis abstinence during the study.

Why it matters

Potential benefit: If successful, this study could provide a novel therapeutic option for managing pain in patients with Complex Regional Pain Syndrome.

How similar studies have gone: While the use of cannabinoids for pain management is being explored, this specific approach in CRPS is relatively novel and has not been extensively tested in prior studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Provision of signed and dated informed consent form.
2. Are between 21-75 years old
3. Ability to communicate in English
4. Volunteers with no previous medical history (e.g., cardiac or pulmonary disease)
5. Are not currently using any type of cannabis, including hemp or CBD
6. Currently 30 days cannabis free
7. Participants with ongoing CRPS \[Type 1 or Type 2)\] for at least 3 months prior to participation (medical record confirmed)
8. Agrees not to use cannabis, including hemp or CBD, outside of the study during participation in the study
9. Agrees not to use opioids or barbiturates during participation in the study

Exclusion Criteria:

1. Fail cannabis screening
2. Active pulmonary disease
3. Allergy or past adverse effects or negative past experiences from cannabis
4. Positive urine drug test for THC, barbiturates, opioids, oxycodone, or methadone prior to study session 1 or session 2
5. Any significant illness, including cardiovascular disease, diabetes, renal and liver disease
6. Any current or history of an immunocompromising disease or condition (such as lupus, psoriasis, multiple sclerosis, etc.)
7. Any current or history of neurologic conditions, including Parkinson disease, dementia, cognitive impairment, history of seizure disorder, and history of traumatic brain injury/head injury
8. Participant meets DSM-V criteria for current major psychiatric illness, such as bipolar disorder, major depression, psychosis, substance use disorder, or schizophrenia
9. Any current or history of suicidal ideation or attempt
10. Patients with clinically significant laboratory abnormalities

Where it's running

  • Altman Clinical and Translational Research Institute
    La Jolla, California, United States
    Recruiting
  • University of California, San Diego
    San Diego, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.